BMY

Bristol-Myers Squibb Co.
Data: 2026-01-30
$55.05
Price
1.02%
Change
$63.33
52W High
$42.52
52W Low

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Quick Stats
Jan 30, 2026

62.2

AI Score

BUY

1.44

Volume Ratio

Feb 05, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

BMY Stock Summary

Last updated Jan 30, 2026

BMY is currently trading at $55.05, positioned above its 200-day moving average of $48.33, indicating a long-term uptrend. The stock has a 52-week range of $42.52 to $63.33.

Technical Analysis: The 50-day moving average stands at $52.83, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 53.317, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.05, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BMY at 62.2/100 with a BUY recommendation.

BMY (Bristol-Myers Squibb Co.) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 53.317
CMF (20) 0.05
ROC (10) -3.082
ADX (14) 27.229
Indicator Value
MACD (12,26,9) 0.473
AROONOSC (14) -28.571
WILLAMS %R (14) -61.946
MFI (14) 45.657
BMY Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BMY Price vs Max Options Open Interest
BMY Max Change In Options Open Interest

BMY Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Daily Out of Money Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Daily In the Money Options - Sort by Max open Interest (near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Most Active Options by Volume(near term)

30th January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Bristol-Myers Squibb Co. is above both 50 Day and 200 Day SMA which is considered Bullish.

BMY Moving Averages Analysis

Bristol-Myers Squibb Co. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

Bristol-Myers Squibb Co. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026

BMY (Bristol-Myers Squibb Co.) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 54.75
20 55.11
30 54.79
50 52.83
100 49.09
200 48.33

BMY Fundamental Analysis

P/E (Forward) 9.3023
P/E (Trailing) 18.3906
Market Cap ($) 111.2 billion
Earnings/Share ($) 2.97
Net Proft Margin (%) 0.1257
Dividend/Share ($) 2.48
EPS Estimate Current Year ($) 6.1548
EPS Estimate Next Year ($) 6.0108
WallStreet Target Price ($) 58.0435
Most Recent Quarter